Detalles de la búsqueda
1.
The effect of neighborhood socioeconomic disadvantage on smoking status, quit attempts, and receipt of cessation support among adults with cancer: Results from nine ECOG-ACRIN Cancer Research Group trials.
Cancer
; 130(3): 439-452, 2024 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37795845
2.
Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.
Cancer
; 130(10): 1747-1757, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38236702
3.
Physicians' Hierarchy of Tumor Biomarkers for Optimizing Chemotherapy in Breast Cancer Care.
Oncologist
; 29(1): e38-e46, 2024 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37405703
4.
Cardiovascular Implications of Vascular Endothelial Growth Factor Inhibition Among Adolescents/Young Adults in ECOG-ACRIN E2805.
J Natl Compr Canc Netw
; 21(7): 725-731.e1, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37433436
5.
Validation of the Lee-Jones theoretical model of fear of cancer recurrence among breast cancer survivors using a structural equation modeling approach.
Psychooncology
; 32(2): 256-265, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36468339
6.
Qualitative similarities and distinctions between participants' experiences with a yoga intervention and an attention control.
Support Care Cancer
; 31(3): 172, 2023 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36795229
7.
Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III-IV melanoma in phase III trial E1609.
Qual Life Res
; 32(1): 183-196, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36029412
8.
Fatigue and endocrine symptoms among women with early breast cancer randomized to endocrine versus chemoendocrine therapy: Results from the TAILORx patient-reported outcomes substudy.
Cancer
; 128(3): 536-546, 2022 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34614209
9.
A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG-ACRIN Cancer Research Group (EAQ152).
Cancer
; 128(7): 1381-1391, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34890045
10.
Physician Perspectives on Reducing Curative Cancer Treatment Intensity for Populations Underrepresented in Clinical Trials.
Oncologist
; 27(12): 1067-1073, 2022 12 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36215065
11.
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.
N Engl J Med
; 380(25): 2395-2405, 2019 06 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31157962
12.
Study protocol for a hybrid type 1 effectiveness-implementation trial testing virtual tobacco treatment in oncology practices [Smokefree Support Study 2.0].
BMC Public Health
; 22(1): 1359, 2022 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35841024
13.
A spotlight on avoidance coping to manage fear of recurrence among breast cancer survivors in an eHealth intervention.
J Behav Med
; 45(5): 771-781, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35930212
14.
Breast cancer patients' insurance status and residence zip code correlate with early discontinuation of endocrine therapy: An analysis of the ECOG-ACRIN TAILORx trial.
Cancer
; 127(14): 2545-2552, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33793979
15.
Tolerability of bevacizumab and chemotherapy in a phase 3 clinical trial with human epidermal growth factor receptor 2-negative breast cancer: A trajectory analysis of adverse events.
Cancer
; 127(24): 4546-4556, 2021 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34726788
16.
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
N Engl J Med
; 379(2): 111-121, 2018 Jul 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29860917
17.
Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial).
Radiology
; 301(1): 66-77, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34342501
18.
Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol
; 21(10): 1317-1330, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32866432
19.
Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204).
Oncologist
; 25(5): e798-e807, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31852811
20.
Implementing electronic health record-integrated screening of patient-reported symptoms and supportive care needs in a comprehensive cancer center.
Cancer
; 125(22): 4059-4068, 2019 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31373682